Patent assignee · CH · COMPANY

Ichnos Sciences SA.

12Patents
12Active
12Granted
47Portfolio score

Filing activity: Oct 19, 2015 → Jun 30, 2022

Most-cited patents

PatentTitleAreaCited byStatus
US11773166B2 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production Chemistry; Metallurgy 2 Active
US10821100B2 Triazolone compounds as mPGES-1 inhibitors Chemistry; Metallurgy 1 Active
US11851502B2 Production of T cell retargeting hetero-dimeric immunoglobulins Chemistry; Metallurgy 1 Active
US11891454B2 Production of T cell retargeting hetero-dimeric immunoglobulins Chemistry; Metallurgy 1 Active
US11970539B2 Antibodies that bind to IL1RAP and uses thereof Chemistry; Metallurgy 0 Active
US11884700B2 Methods of inactivating viral contaminants Chemistry; Metallurgy 0 Active
US10758517B2 mPGES-1 inhibitor for the treatment of osteoarthritis pain Human Necessities 0 Active
US11407839B2 Antibodies that bind to OX40 and their uses Physics 0 Active
US12281169B2 Antibodies that bind to OX40 and their uses Physics 0 Active
US12006367B2 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production Chemistry; Metallurgy 0 Active
US10640564B2 Antibodies that bind to CCR6 and their uses Chemistry; Metallurgy 0 Active
US12351602B2 Methods of inactivating viral contaminants Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.